All GLP-one class medications carry boxed warnings about thyroid C-cell tumors noticed in rodent research, though this chance has not been confirmed in humans. The Choose cardiovascular outcomes demo demonstrated that semaglutide in fact reduced major adverse cardiovascular situations by twenty%, providing reassurance about long-term cardiovascular… Read More